A closely-watched federal prison conspiracy trial for Denver-based DaVita Inc. and the corporate’s former CEO has been delayed by one week.
The trial, which had been set to start Monday in U.S. District Court docket for the District of Colorado, was on Saturday rescheduled to start out April 4, courtroom information present.
A motive for the delay was not instantly clear.
Denver-based DaVita, one of many nation’s largest suppliers of kidney dialysis companies, and former CEO Kent Thiry will stand trial on three counts of conspiracy in reference to allegations that DaVita and its opponents agreed to not recruit every others’ staff.
The federal trial is the primary time an organization or CEO has been criminally charged for so-called non-poaching agreements below the 132-year-old Sherman Anti-Belief Act, and is predicted to reverberate nationally.
Prosecutors say the agreements between DaVita, Thiry and three different well being care companies to not recruit DaVita’s workers restricted staff’ skill to hunt out increased wages, advance their careers and compete in a free market.
The corporate has argued in courtroom filings that such agreements should not unlawful and that prosecutors are stretching federal antitrust legal guidelines to deliver the conspiracy expenses.
The trial is now set to start with jury choice April 4 at 9 a.m. earlier than Senior Decide R. Brooke Jackson.
